FDA approves Lucemyra to treat symptoms of opioid withdrawal and help patients overcome addiction
by Karen Kaplan, Los Angeles Times
May 17, 2018
2 minutes
The battle against opioid addiction in the United States got a new weapon Wednesday, in the form of a pill to help patients manage symptoms of withdrawal.
The Food and Drug Administration said it gave its seal of approval to Lucemyra, a medication that has been used to treat opioid withdrawal in the
You’re reading a preview, subscribe to read more.
Start your free 30 days